Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care

Completed · Not applicable

Conditions studied: Non-Small Cell Lung Carcinoma (NSCLC)

In brief

The objective of this study is to 1) evaluate the impact of a novel individualized care planning/ educational technology (the On Q Care Planning System or CPS) on oncology patient and provider knowledge, attitudes and beliefs about Non-Small Cell Lung Carcinoma (NSCLC) clinical trials, as well as 2) to evaluate the impact of the On Q CPS on patient referral to and enrollment in NSCLC clinical trials.

Key facts

Study ID

NCT02558998

Run by

Abramson Cancer Center at Penn Medicine

People needed

120

Starts

2015-03-01

Expected to finish

2019-03-01

Last updated by the study team

2020-02-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All participants must be 18 years of age or older.
• Patient participants must have Stage III, IV and/or recurrent NSCLC.
• Patient participants must be at a point of treatment initiation/change or evaluation for treatment initiation/change
• Patients must have working email address and internet access

You may not qualify if…

• Any participant who cannot understand written or spoken English.
• Any participant who is not competent to provide informed consent for study participation per the investigator.
• Any participant who cannot be present for the related study visits and/or complete the post-test assessment

Where it is running

• Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.